Tabernero, J., Homicsko, K., Schellens, J., Hoekstra, O., Van der Veen, L., Melero, I., és, G. A., Mau-Sorensen, M., Angevin, E., Joensuu, H., Van Brummelen, E., van Oordt, C. M. d. H., Nayak, T., Romagnoli, S., Reis, B., Brossard, S. S., Evers, S., Saro, J., Verheul, H., & Lassen, U. (n.d.). 505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine. European journal of cancer, 51, S104–S105. http://access.bl.uk/ark:/81055/vdc_100030628020.0x00004f